Alzheimer’s disease is the holy grail of pharmaceutical research, and a team of physicians published results showing that they may have found the key to actually improving cognition in patients with early-stage dementia.
https://www.pharmalive.com/wp-content/uploads/2021/05/Precision-Medicine-Study-Points-to-Promising-New-Approach-in-Alzheimers-BioSPace-5-21-21.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2021-05-21 12:09:092021-05-21 12:10:51Precision Medicine Study Points to Promising New Approach in Alzheimer’s